View recent articles in Biopharma News
BioPharma Dive is a leading industry publication providing in-depth journalism and insight into »
Endpoints News is an independent news organization, reports and analyzes the top global biotech »
BioPharm International integrates the science and business of biopharmaceuticals through print »
News on the biopharmaceutical manufacturing industry, focusing on biologics, technology, upstream »
Breaking news from the biotech, clinical research and pharmaceutical industries. BioSpace is The »
Digital publication for experts in drug discovery, pharma, and biotech. Join to influence the »
Relmada sinks further as depression drug fails second large trial 
WIB22: She reshaped migraine science and led key trials for new drugs, but Sheena Aurora isn’t done 
Nearly out of cash, a former Sarepta partner asks French courts to oversee restructuring 
Sensei and Instil Bio let go large chunks of workforces, shift pipelines 
FDA halts imports of several Sun Pharma drugs made in India due to outstanding quality issues 
Scoop: Gilead terminates early-stage FLT3 trial in solid tumors 
Dantari emerges with a new way to make cancer drug conjugates 
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2023 Kewaunee Scientific Corporation announced results for its second quarter ended October 31, 2022. Hansa Biopharma announces positive reimbursement decision in Italy for Idefirix® (imlifidase) as desensitization treatment for highly sensitized patients in kidney transplantation Hansa Biopharma announces that the Italian Medicine Agency has granted full access and reimbursement for the use of Idefirix®, the company's.. 
GSK, Sanofi, and Takeda Partner With Singapore to Boost Biologics Innovation 
The Top 10 R&D Scientist Skills in High Demand 
Neurocrine’s $50M Neuro Asset Takes Strike Two 
Lilly and Boehringer's Jardiance Racks Up Another Type 2 Diabetes Win 
Paragon Births Apogee to Address Unmet Need in Immunology/Inflammatory Space 
Enabling Pharma 4.0 Using AI: Interview With Rajiv Anand, Founder of Quartic.ai 
Trailing rivals, Editas shares first study data for sickle cell treatment 
Immune drug developer Apogee emerges as first spinout of biotech Paragon 
Prometheus shares soar on new data for inflammation drug 
Oral biologics: Rani reports positive clinical data for osteoporosis targeting capsule 
Antibody drug discovery biotech raises $12m in seed funding 
GSK, Sanofi, and Takeda align with research communities to advance Singapore's biologics manufacturing capabilities 
Licensing deal aimed at progressing cell and gene therapies in the treatment of rare diseases 
Vaxxas raises $23m for needle-free vaccine clinical development and manufacturing 
Multi-Attribute Methods for Biopharmaceutical Analysis 
Controlling Quality in Aging Facilities 
Digitalization of Biomanufacturing: A Status Update 
Pandemic and Politics Shaped Pharma and FDA in 2022 
Artificial Intelligence in Drug Discovery and Biotech: 2022 Recap and Key Trends 
Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR® 
11 AI-powered Drug Discovery Startups Founded in 2021 
How “Big Tech” is Slowly Winning Pharmaceutical Markets